These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24716965)

  • 1. Clinical value of dividing false positive urine cytology findings into three categories: atypical, indeterminate, and suspicious of malignancy.
    Matsumoto K; Ikeda M; Hirayama T; Nishi M; Fujita T; Hattori M; Sato Y; Ohbu M; Iwamura M
    Asian Pac J Cancer Prev; 2014; 15(5):2251-5. PubMed ID: 24716965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of false-negative for high-grade urothelial carcinoma in urine cytology.
    Lee PJ; Owens CL; Lithgow MY; Jiang Z; Fischer AH
    Diagn Cytopathol; 2016 Dec; 44(12):994-999. PubMed ID: 27781412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
    Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
    Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical Category of the Johns Hopkins Template Has Higher Risk of Malignancy than the Paris System but the Paris System Is More Applicable for Suspicious Category.
    Celik B; Kavas G
    Acta Cytol; 2023; 67(4):425-433. PubMed ID: 36731438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinical significance of class III (suspicious) urine cytology.
    Sternberg I; Rona R; Olsfanger S; Lew S; Leibovitch I
    Cytopathology; 2011 Oct; 22(5):329-33. PubMed ID: 21114557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a Machine Learning Algorithm for Identifying Abnormal Urothelial Cells: A Feasibility Study.
    Zhang Z; Fu X; Liu J; Huang Z; Liu N; Fang F; Rao J
    Acta Cytol; 2021; 65(4):335-341. PubMed ID: 33022673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-year study on the application of the Paris system for urinary cytology in a cancer centre.
    de Paula R; Oliveira A; Nunes W; Bovolim G; Domingos T; De Brot L; Bezerra S; Cunha I; Morini M; Saieg M
    Cytopathology; 2020 Jan; 31(1):41-46. PubMed ID: 31654587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study.
    VandenBussche CJ; Sathiyamoorthy S; Owens CL; Burroughs FH; Rosenthal DL; Guan H
    Cancer Cytopathol; 2013 Jan; 121(1):21-8. PubMed ID: 23192913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence-based diagnostic accuracy measurement in urine cytology using likelihood ratios.
    Myles N; Auger M; Kanber Y; Caglar D; Kassouf W; Brimo F
    J Am Soc Cytopathol; 2021; 10(1):71-78. PubMed ID: 33071190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary tract cytology: a cytologic-histopathologic correlation with The Paris System, an institutional study.
    Danakas A; Sweeney M; Cheris S; Agrawal T
    J Am Soc Cytopathol; 2021; 10(1):56-63. PubMed ID: 33132054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytologic difference between benignity and malignancy in suspicious cases employing urine cytodiagnosis using a liquid-based method.
    Washiya K; Sato T; Miura T; Tone K; Kojima K; Watanabe J; Kijima H
    Anal Quant Cytol Histol; 2011 Jun; 33(3):169-74. PubMed ID: 21980620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Implementing the Paris System for Reporting Urine Cytology in the Performance of Urine Cytology:  A Correlative Study of 124 Cases.
    Hassan M; Solanki S; Kassouf W; Kanber Y; Caglar D; Auger M; Brimo F
    Am J Clin Pathol; 2016 Sep; 146(3):384-90. PubMed ID: 27543983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical follow up and the impact of the Paris system in the assessment of patients with atypical urine cytology.
    Northrup V; Acar BC; Hossain M; Acker MR; Manuel E; Rahmeh T
    Diagn Cytopathol; 2018 Dec; 46(12):1022-1030. PubMed ID: 30375194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Paris System for reporting urinary cytology in daily practice with emphasis on ancillary testing by multiprobe FISH.
    Vlajnic T; Gut A; Savic S; Bubendorf L
    J Clin Pathol; 2020 Feb; 73(2):90-95. PubMed ID: 31467041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of The Paris System in neobladder washing cytology: Comparison between the original diagnosis and correlation with histopathology.
    Kim JM; Lee J; Sung SH
    Diagn Cytopathol; 2023 Dec; 51(12):744-750. PubMed ID: 37610033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytohistological correlation of urine cytology in a tertiary centre with application of the Paris system.
    Rohilla M; Singh P; Rajwanshi A; Gupta N; Srinivasan R; Dey P; Kakkar N
    Cytopathology; 2018 Oct; 29(5):436-443. PubMed ID: 29920811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative phase imaging to improve the diagnostic accuracy of urine cytology.
    Pham HV; Pantanowitz L; Liu Y
    Cancer Cytopathol; 2016 Sep; 124(9):641-50. PubMed ID: 27177072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results.
    McHale T; Ohori NP; Cieply KM; Sherer C; Bastacky SI
    Diagn Cytopathol; 2019 Apr; 47(4):282-288. PubMed ID: 30417563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokeratin 20 immunocytochemistry on urine sediments: A potential low-cost adjunct to cytology in the diagnosis of low-grade urothelial carcinoma.
    Wadhwa N; Diwaker P; Lotha N; Arora VK; Singh N
    Cytopathology; 2017 Dec; 28(6):531-535. PubMed ID: 28940433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of urine cytology diagnostic reports before and after the implementation of the Paris System classification system in China.
    Ma C; Zhang L
    Cytopathology; 2020 Sep; 31(5):457-462. PubMed ID: 32246545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.